Leuko Labs develops non-invasive white blood cell monitoring device.
Leuko Labs has raised €1.6M across 1 funding round from 1 investor, most recently a Seed round in Jul 2019. Based in Madrid, Spain; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Seed | €1.6M |
| Good Growth Capital |
| View deal → |
